Arvinas Inc [ARVN] stock prices are up 12.42% to $8.60 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ARVN shares have gain 29.91% over the last week, with a monthly amount drifted -1.15%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Arvinas Inc [NASDAQ: ARVN] stock has seen the most recent analyst activity on March 13, 2025, when Goldman downgraded its rating to a Neutral and also revised its price target to $15 from $70. Previously, Wedbush downgraded its rating to Neutral on March 12, 2025, and dropped its price target to $12. On March 11, 2025, downgrade downgraded it’s rating to Perform. BTIG Research started tracking the stock assigning a Buy rating and suggested a price target of $69 on December 10, 2024. Stephens initiated its recommendation with a Overweight and recommended $55 as its price target on November 18, 2024. Oppenheimer reiterated a Outperform rating for this stock on February 28, 2024, and downed its price target to $80. In a note dated February 14, 2024, Citigroup downgraded an Neutral rating on this stock and boosted its target price from $36 to $55.
The stock price of Arvinas Inc [ARVN] has been fluctuating between $5.93 and $37.38 over the past year. Currently, Wall Street analysts expect the stock to reach $41.71 within the next 12 months. Arvinas Inc [NASDAQ: ARVN] shares were valued at $8.60 at the most recent close of the market. An investor can expect a potential return of 385.0% based on the average ARVN price forecast.
Analyzing the ARVN fundamentals
The Arvinas Inc [NASDAQ:ARVN] reported sales of 161.00M for trailing twelve months, representing a surge of 237.35%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.95%, Pretax Profit Margin comes in at -0.75%, and Net Profit Margin reading is -0.76%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.34 and Total Capital is -0.29. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.92 points at the first support level, and at 7.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.96, and for the 2nd resistance point, it is at 9.32.
Ratios To Look Out For
It’s worth pointing out that Arvinas Inc [NASDAQ:ARVN]’s Current Ratio is 4.64. As well, the Quick Ratio is 4.64, while the Cash Ratio is 0.44. Considering the valuation of this stock, the price to sales ratio is 3.67, the price to book ratio is 1.05.
Transactions by insiders
Recent insider trading involved Berkowitz Noah, Chief Medical Officer, that happened on Mar 18 ’25 when 8658.0 shares were sold. Officer, Noah Berkowitz completed a deal on Mar 18 ’25 to buy 8658.0 shares. Meanwhile, Chief Accounting Officer Loomis David K sold 1214.0 shares on Feb 24 ’25.
